Piper Sandler Maintains Overweight on InspireMD, Raises Price Target to $4.5
BenzingaNov 3, 2023 03:58
InspireMD Analyst Ratings
BenzingaNov 3, 2023 03:56
Piper Sandler Remains a Buy on InspireMD (NSPR)
TipRanksSep 25, 2023 18:55
Alliance Global Adjusts Price Target on InspireMD to $4.75 From $5.15, Maintains Buy Rating
MT NewswiresMay 17, 2023 22:09
National Alliance Securities Maintains Buy on InspireMD, Lowers Price Target to $4.75
BenzingaMay 17, 2023 21:52
Alliance Global Partners Maintains Buy on InspireMD, Lowers Price Target to $5.15
BenzingaApr 1, 2023 01:10
No Data
No Data